{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:25:43Z","timestamp":1787163943481,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.imbio.2022.152272","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T23:59:08Z","timestamp":1662508748000},"page":"152272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["STAT1 is associated with NK cell dysfunction by downregulating NKG2D transcription in chronic HBV-infected patients"],"prefix":"10.1016","volume":"227","author":[{"given":"Xiaojuan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2022.152272_b0005","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1007\/s00018-015-1911-5","article-title":"Natural killer cell heterogeneity: cellular dysfunction and significance in HIV-1 immuno-pathogenesis","volume":"72","author":"Ansari","year":"2015","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"issue":"5428","key":"10.1016\/j.imbio.2022.152272_b0010","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.imbio.2022.152272_b0015","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1084\/jem.20062026","article-title":"Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D","volume":"204","author":"Campbell","year":"2007","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.imbio.2022.152272_b0020","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/hep.30317","article-title":"Natural killer cell-derived interferon-gamma promotes hepatocellular carcinoma through the epithelial cell adhesion molecule-epithelial-to-mesenchymal transition axis in hepatitis B virus transgenic mice","volume":"69","author":"Chen","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.imbio.2022.152272_b0025","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1182\/blood-2008-04-154682","article-title":"Interleukin-6\/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities","volume":"113","author":"Eddahri","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2022.152272_b0030","doi-asserted-by":"crossref","first-page":"e1048061","DOI":"10.1080\/2162402X.2015.1048061","article-title":"Failure recovery of circulating NKG2D(+)CD56(dim)NK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence","volume":"5","author":"Gao","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.imbio.2022.152272_b0035","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.3389\/fimmu.2019.02590","article-title":"JAK\/STAT cytokine signaling at the crossroad of NK cell development and maturation","volume":"10","author":"Gotthardt","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2022.152272_b0040","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1053\/jhep.2002.33638","article-title":"Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B","volume":"35","author":"Hsu","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.imbio.2022.152272_b0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.humimm.2019.11.006","article-title":"Impaired circulating CD56(dim) NK cells are associated with decompensation of HBV-related cirrhosis","volume":"81","author":"Jiang","year":"2020","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.imbio.2022.152272_b0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.imlet.2020.12.008","article-title":"Highly activated TRAIL(+) CD56(bright) NK cells are associated with the liver damage in HBV-LC patients","volume":"232","author":"Jiang","year":"2021","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imbio.2022.152272_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2019.02.007","article-title":"IL-21 reinvigorates exhausted natural killer cells in patients with HBV-associated hepatocellular carcinoma in STAT1-depedent pathway","volume":"70","author":"Jin","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.imbio.2022.152272_b0060","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jhep.2009.12.005","article-title":"T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B","volume":"52","author":"Ju","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.imbio.2022.152272_b0065","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s41467-019-08743-8","article-title":"STAT1 signaling shields T cells from NK cell-mediated cytotoxicity","volume":"10","author":"Kang","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.imbio.2022.152272_b0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imbio.2022.152272_b0075","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.3389\/fimmu.2019.02689","article-title":"Impairment of NKG2D-mediated tumor immunity by TGF-\u03b2","volume":"10","author":"Lazarova","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.imbio.2022.152272_b0080","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.4049\/jimmunol.165.7.3571","article-title":"Distinct requirements for IFNs and STAT1 in NK cell function","volume":"165","author":"Lee","year":"2000","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.imbio.2022.152272_b0085","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1136\/gutjnl-2017-314098","article-title":"Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection","volume":"67","author":"Li","year":"2018","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.imbio.2022.152272_b0090","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12072-009-9140-3","article-title":"HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B","volume":"3","author":"Liaw","year":"2009","journal-title":"Hep. Intl."},{"issue":"3","key":"10.1016\/j.imbio.2022.152272_b0095","doi-asserted-by":"crossref","first-page":"108627","DOI":"10.1016\/j.celrep.2020.108627","article-title":"Critical role of Syk-dependent STAT1 activation in innate antiviral immunity","volume":"34","author":"Liu","year":"2021","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.imbio.2022.152272_b0100","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/j.gastro.2016.07.012","article-title":"HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant","volume":"151","author":"Mason","year":"2016","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.imbio.2022.152272_b0105","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/cyto.a.22302","article-title":"Human NK cell receptors\/markers: a tool to analyze NK cell development, subsets and function","volume":"83A","author":"Montaldo","year":"2013","journal-title":"Cytometry Part A"},{"key":"10.1016\/j.imbio.2022.152272_b0110","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/gut.2005.076463","article-title":"Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C","volume":"55","author":"Nattermann","year":"2006","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.imbio.2022.152272_b0115","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3390\/jcm8060842","article-title":"Indoleamine-2,3-dioxygenase in thyroid cancer cells suppresses natural killer cell function by inhibiting NKG2D and NKp46 expression via STAT signaling pathways","volume":"8","author":"Park","year":"2019","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.imbio.2022.152272_b0120","doi-asserted-by":"crossref","first-page":"e1001227","DOI":"10.1371\/journal.ppat.1001227","article-title":"Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection","volume":"6","author":"Peppa","year":"2010","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.imbio.2022.152272_b0125","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/eji.202049028","article-title":"Human NK cells, their receptors and function","volume":"51","author":"Quatrini","year":"2021","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.imbio.2022.152272_b0130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1089\/jir.2015.0054","article-title":"STAT5 in cancer and immunity","volume":"36","author":"Rani","year":"2016","journal-title":"J. Interferon Cytokine Res."},{"issue":"11","key":"10.1016\/j.imbio.2022.152272_b0135","doi-asserted-by":"crossref","first-page":"e1002362","DOI":"10.1371\/journal.ppat.1002362","article-title":"The human herpesvirus-7 (HHV-7) U21 immunoevasin subverts NK-mediated cytoxicity through modulation of MICA and MICB","volume":"7","author":"Schneider","year":"2011","journal-title":"PLoS Pathog."},{"issue":"10161","key":"10.1016\/j.imbio.2022.152272_b0140","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/S0140-6736(18)31865-8","article-title":"Chronic hepatitis B virus infection","volume":"392","author":"Seto","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2022.152272_b0145","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nri1226","article-title":"Regulation of JAK-STAT signalling in the immune system","volume":"3","author":"Shuai","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"24","key":"10.1016\/j.imbio.2022.152272_b0150","doi-asserted-by":"crossref","first-page":"36074","DOI":"10.18632\/oncotarget.8683","article-title":"Defective STAT1 activation associated with impaired IFN-\u03b3 production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2","volume":"7","author":"Sim","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.imbio.2022.152272_b0155","doi-asserted-by":"crossref","unstructured":"Simma, O., Zebedin, E., Neugebauer, N., Schellack, C., Pilz, A., Chang-Rodriguez, S., Lingnau, K., Weisz, E., Putz, E. M., Pickl, W. F., Felzmann, T., M\u00fcller, M., Decker, T., Sexl, V., Stoiber, D. (2009) Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor surveillance. Cancer Res. 69, 203\u201311.","DOI":"10.1158\/0008-5472.CAN-08-1705"},{"issue":"1","key":"10.1016\/j.imbio.2022.152272_b0160","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/imr.12705","article-title":"JAK\/STAT signaling in regulation of innate lymphoid cells: The gods before the guardians","volume":"286","author":"Stabile","year":"2018","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.imbio.2022.152272_b0165","doi-asserted-by":"crossref","first-page":"e1002594","DOI":"10.1371\/journal.ppat.1002594","article-title":"TGF-\u03b21 down-regulation of NKG2D\/DAP10 and 2B4\/SAP expression on human NK cells contributes to HBV persistence","volume":"8","author":"Sun","year":"2012","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.imbio.2022.152272_b0170","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/cmi.2014.91","article-title":"NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma","volume":"12","author":"Sun","year":"2015","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2022.152272_b0175","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.jaci.2017.08.040","article-title":"Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations","volume":"141","author":"Vargas-Hern\u00e1ndez","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6013","key":"10.1016\/j.imbio.2022.152272_b0180","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.imbio.2022.152272_b0185","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41598-017-00221-9","article-title":"NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imbio.2022.152272_b0190","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3892\/etm.2021.9982","article-title":"Role of STAT1 in the resistance of HBV to IFN-\u03b1","volume":"21","author":"Xu","year":"2021","journal-title":"Exp. Therapeutic Med."},{"issue":"3","key":"10.1016\/j.imbio.2022.152272_b0195","doi-asserted-by":"crossref","first-page":"e0174103","DOI":"10.1371\/journal.pone.0174103","article-title":"Frequency and role of NKp46 and NKG2A in hepatitis B virus infection","volume":"12","author":"Yoshioka","year":"2017","journal-title":"PloS One"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298522000985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298522000985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:49:39Z","timestamp":1759250979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298522000985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0171298522000985"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2022.152272","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STAT1 is associated with NK cell dysfunction by downregulating NKG2D transcription in chronic HBV-infected patients","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2022.152272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152272"}}